PKA and Epac activation mediates cAMP-induced vasorelaxation by increasing endothelial NO production
Garcia-Morales, V. Cuíñas, A. Campos-Toimil, M.
Garcia-Morales, V.
Cuíñas, A.
Campos-Toimil, M.
Publication Date
2014-03
End of Embargo
Supervisor
Rights
Peer-Reviewed
Yes
Open Access status
closedAccess
Accepted for publication
2014-01-17
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
Vascular relaxation induced by 3′,5′-cyclic adenosine monophosphate (cAMP) is both endothelium-dependent and endothelium-independent, although the underlying signaling pathways are not fully understood. Aiming to uncover potential mechanisms, we performed contraction–relaxation experiments on endothelium-denuded and intact rat aorta rings and measured NO levels in isolated human endothelial cells using single cell fluorescence imaging. The vasorelaxant effect of forskolin, an adenylyl cyclase activator, was decreased after selective inhibitor of protein kinase A (PKA), a cAMP-activated kinase, or L-NAME, an endothelial nitric oxide synthase (eNOS) inhibitor, only in intact aortic rings. Both selective activation of PKA with 6-Bnz-cAMP and exchange protein directly activated by cAMP (Epac) with 8-pCPT-2′–O-Me-cAMP significantly relaxed phenylephrine-induced contractions. The vasorelaxant effect of the Epac activator, but not that of the PKA activator, was reduced by endothelium removal. Forskolin, dibutyryl cAMP (a cAMP analogue), 6-Bnz-cAMP and 8-pCPT-2′–O-Me-cAMP increased NO levels in endothelial cells and the forskolin effect was significantly inhibited by inactivation of both Epac and PKA, and eNOS inhibition. Our results indicate that the endothelium-dependent component of forskolin/cAMP-induced vasorelaxation is partially mediated by an increase in endothelial NO release due to an enhanced eNOS activity through PKA and Epac activation in endothelial cells.
Version
No full-text in the repository
Citation
Garcia-Morales V, Cuíñas A, Elies J et al (2014) PKA and Epac activation mediates cAMP-induced vasorelaxation by increasing endothelial NO production. Vascular Pharmacology. 60(3): 95-101.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article